of TLR9abortus Is Dependent on Triggering Th1-Like Cytokine Induction by Heat-Killed

Basil GoldingLi-Yun Huang, Ken J. Ishii, Shizuo Akira, Julio Aliberti andhttp://www.jimmunol.org/content/175/6/3964J Immunol€2005; 175:3964-3970; ;Referenceshttp://www.jimmunol.org/content/175/6/3964.full#ref-list-1This article cites 65 articles, 32 of which you can access for free at: Subscriptionshttp://jimmunol.org/subscriptionsInformation about subscribing to The Journal of Immunology is online at: Permissionshttp://www.aai.org/ji/copyright.htmlSubmit copyright permission requests at: Email Alertshttp://jimmunol.org/cgi/alerts/etocReceive free email-alerts when new articles cite this article. Sign up at:

[1]  A. Krieg,et al.  Inhibitory oligonucleotides specifically block effects of stimulatory CpG oligonucleotides in B cells , 2002, European journal of immunology.

[2]  B. Golding,et al.  Human Peripheral Blood T Cells, Monocytes, and Macrophages Secrete Macrophage Inflammatory Proteins 1α and 1β following Stimulation with Heat-Inactivated Brucella abortus , 2001, Infection and Immunity.

[3]  T. Di Pucchio,et al.  The natural alliance between type I interferon and dendritic cells and its role in linking innate and adaptive immunity. , 2002, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[4]  D. Scott,et al.  Inhibition of primary and recall allergen-specific T helper cell type 2-mediated responses by a T helper cell type 1 stimulus. , 1997, Journal of immunology.

[5]  A. Bowie,et al.  The Toll-IL-1 receptor adaptor family grows to five members. , 2003, Trends in immunology.

[6]  M. Fenton,et al.  TLRs: differential adapter utilization by toll-like receptors mediates TLR-specific patterns of gene expression. , 2003, Molecular interventions.

[7]  K. Ishii,et al.  Immunotherapeutic utility of stimulatory and suppressive oligodeoxynucleotides. , 2004, Current opinion in molecular therapeutics.

[8]  C. Snapper,et al.  Both Innate Immunity and Type 1 Humoral Immunity to Streptococcus pneumoniae Are Mediated by MyD88 but Differ in Their Relative Levels of Dependence on Toll-Like Receptor 2 , 2005, Infection and Immunity.

[9]  D. Scott,et al.  HIV peptide conjugated to heat-killed bacteria promotes antiviral responses in immunodeficient mice. , 1998, AIDS research and human retroviruses.

[10]  E. Moreno,et al.  Brucella intracellular life: from invasion to intracellular replication. , 2002, Veterinary microbiology.

[11]  M. Kruhlak,et al.  TLR9 Is Localized in the Endoplasmic Reticulum Prior to Stimulation , 2004, The Journal of Immunology.

[12]  K. Ishii,et al.  Potential Role of Phosphatidylinositol 3 Kinase, rather than DNA-dependent Protein Kinase, in CpG DNA–induced Immune Activation , 2002, The Journal of experimental medicine.

[13]  K. Ishii,et al.  Cutting Edge: Role of Toll-Like Receptor 9 in CpG DNA-Induced Activation of Human Cells1 , 2001, The Journal of Immunology.

[14]  B. Monks,et al.  TLR9 signals after translocating from the ER to CpG DNA in the lysosome , 2004, Nature Immunology.

[15]  Zhang Qing,et al.  Completion of the Genome Sequence of Brucella abortus and Comparison to the Highly Similar Genomes of Brucella melitensis and Brucella suis , 2005, Journal of bacteriology.

[16]  T. Mosmann,et al.  The expanding universe of T-cell subsets: Th1, Th2 and more. , 1996, Immunology today.

[17]  D. Pisetsky,et al.  Inhibition of murine dendritic cell activation by synthetic phosphorothioate oligodeoxynucleotides , 2002, Journal of leukocyte biology.

[18]  A. Sher,et al.  Cutting Edge: MyD88 Is Required for Resistance to Toxoplasma gondii Infection and Regulates Parasite-Induced IL-12 Production by Dendritic Cells1 , 2002, The Journal of Immunology.

[19]  D. Klinman,et al.  Suppressive Oligodeoxynucleotides Protect Mice from Lethal Endotoxic Shock1 , 2005, The Journal of Immunology.

[20]  M. Philipp,et al.  Lipoproteins, Not Lipopolysaccharide, Are the Key Mediators of the Proinflammatory Response Elicited by Heat-Killed Brucella abortus1 , 2004, The Journal of Immunology.

[21]  D. Golenbock,et al.  Mechanisms of TLR9 activation , 2004, Journal of endotoxin research.

[22]  T. Giese,et al.  Activation with CpG-A and CpG-B Oligonucleotides Reveals Two Distinct Regulatory Pathways of Type I IFN Synthesis in Human Plasmacytoid Dendritic Cells 1 , 2003, The Journal of Immunology.

[23]  D. Scott,et al.  Induction and Regulation of Th1-Inducing Cytokines by Bacterial DNA, Lipopolysaccharide, and Heat-Inactivated Bacteria , 1999, Infection and Immunity.

[24]  S. Akira,et al.  The Roles of Toll-Like Receptor 9, MyD88, and DNA-Dependent Protein Kinase Catalytic Subunit in the Effects of Two Distinct CpG DNAs on Dendritic Cell Subsets1 , 2003, The Journal of Immunology.

[25]  C. Coban,et al.  Interferon-α induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6 , 2004, Nature Immunology.

[26]  David A. Hume,et al.  The Molecular Basis for the Lack of Immunostimulatory Activity of Vertebrate DNA1 , 2003, The Journal of Immunology.

[27]  M. Betts,et al.  Human peripheral blood CD4+ and CD8+ T cells express Th1-like cytokine mRNA and proteins following in vitro stimulation with heat-inactivated Brucella abortus , 1995, Infection and immunity.

[28]  W. Brown,et al.  DNA and a CpG Oligonucleotide Derived fromBabesia bovis Are Mitogenic for Bovine B Cells , 1998, Infection and Immunity.

[29]  A. Sher,et al.  Biochemical characterization and protein kinase C dependency of monokine-inducing activities of Toxoplasma gondii , 1996, Infection and immunity.

[30]  C. Hunter,et al.  TLR Ligands Can Activate Dendritic Cells to Provide a MyD88-Dependent Negative Signal for Th2 Cell Development1 , 2005, The Journal of Immunology.

[31]  M. Jackson,et al.  Dual function of Drosophila cells as APCs for naive CD8+ T cells: implications for tumor immunotherapy. , 1996, Immunity.

[32]  H. Wagner.  The immunobiology of the TLR9 subfamily. , 2004, Trends in immunology.

[33]  S. Akira,et al.  A Toll-like receptor recognizes bacterial DNA , 2000, Nature.

[34]  G. Splitter,et al.  Molecular Host-Pathogen Interaction in Brucellosis: Current Understanding and Future Approaches to Vaccine Development for Mice and Humans , 2003, Clinical Microbiology Reviews.

[35]  W. Paul,et al.  T‐independent responses in B cell‐defective CBA/N mice to Brucella abortus and to trinitrophenyl (TNP) conjugates of Brucella abortus , 1978, European journal of immunology.

[36]  T. Decker,et al.  IFNs and STATs in innate immunity to microorganisms. , 2002, The Journal of clinical investigation.

[37]  C. Cheers,et al.  Control of IL-12 and IFN-gamma production in response to live or dead bacteria by TNF and other factors. , 1998, Journal of immunology.

[38]  K. Ishii,et al.  Human Peripheral Blood Cells Differentially Recognize and Respond to Two Distinct CpG Motifs1 2 , 2001, The Journal of Immunology.

[39]  S. Akira,et al.  Toll-like receptors in innate immunity. , 2004, International immunology.

[40]  G. Bishop,et al.  CpG motifs in bacterial DNA trigger direct B-cell activation , 1995, Nature.

[41]  B. Golding,et al.  Brucella abortus conjugated with a peptide derived from the V3 loop of human immunodeficiency virus (HIV) type 1 induces HIV-specific cytotoxic T-cell responses in normal and in CD4+ cell-depleted BALB/c mice , 1996, Journal of virology.

[42]  E. Raz,et al.  Cutting Edge: Activation of Toll-Like Receptor 2 Induces a Th2 Immune Response and Promotes Experimental Asthma1 , 2004, The Journal of Immunology.

[43]  Nammalwar Sriranganathan,et al.  Brucellosis vaccines: past, present and future. , 2002, Veterinary microbiology.

[44]  D. Tough,et al.  Links between innate and adaptive immunity via type I interferon. , 2002, Current opinion in immunology.

[45]  Shizuo Akira,et al.  Toll-like Receptor Signaling* , 2003, Journal of Biological Chemistry.

[46]  M. J. Corbel,et al.  Brucellosis: an overview. , 1997, Emerging infectious diseases.

[47]  Yasushi Itoh,et al.  IL-12 Induction by a Th1-Inducing Adjuvant In Vivo: Dendritic Cell Subsets and Regulation by IL-10 , 2001, The Journal of Immunology.

[48]  V. Hornung,et al.  Identification of CpG oligonucleotide sequences with high induction of IFN‐α/β in plasmacytoid dendritic cells , 2001 .

[49]  N. Blyveis,et al.  Brucella abortus conjugated with a gp120 or V3 loop peptide derived from human immunodeficiency virus (HIV) type 1 induces neutralizing anti-HIV antibodies, and the V3-B. abortus conjugate is effective even after CD4+ T-cell depletion , 1995, Journal of virology.

[50]  D. Scott,et al.  Immunity and protection against Brucella abortus. , 2001, Microbes and infection.

[51]  T. Wu,et al.  Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[52]  C. Baldwin,et al.  Fundamentals of host immune response against Brucella abortus: what the mouse model has revealed about control of infection. , 2002, Veterinary microbiology.

[53]  A. Krieg,et al.  CpG motifs in bacterial DNA and their immune effects. , 2002, Annual review of immunology.

[54]  A. Sher,et al.  CCR5 provides a signal for microbial induced production of IL-12 by CD8α+ dendritic cells , 2000, Nature Immunology.

[55]  S. Akira,et al.  Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. , 1998, Immunity.

[56]  R. Coffman,et al.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. , 1989, Annual review of immunology.

[57]  R. Zeuner,et al.  Differential signaling by CpG DNA in DCs and B cells: not just TLR9. , 2003, Trends in immunology.

[58]  Ruslan Medzhitov,et al.  Toll-Like Receptor Signaling Pathways , 2003, Science.

[59]  A. Bird.  CpG islands as gene markers in the vertebrate nucleus , 1987 .

[60]  S. Akira,et al.  Toll-like Receptor 9–mediated Recognition of Herpes Simplex Virus-2 by Plasmacytoid Dendritic Cells , 2003, The Journal of experimental medicine.

[61]  T. Ficht.  Intracellular survival of Brucella: defining the link with persistence. , 2003, Veterinary microbiology.

[62]  R. Vabulas,et al.  Bacterial CpG‐DNA and lipopolysaccharides activate Toll‐like receptors at distinct cellular compartments , 2002, European journal of immunology.

[63]  C. Bogdan,et al.  The role of type I interferons in non‐viral infections , 2004, Immunological reviews.

[64]  K. Ishii,et al.  Effect of Suppressive DNA on CpG-Induced Immune Activation1 , 2002, The Journal of Immunology.

[65]  A. Fauci,et al.  Immunologic abnormalities in the acquired immunodeficiency syndrome. , 1985, Annual review of immunology.